Perkinelmer (PKI) 46.30 $PKI
PerkinElmer Elects Sylvie Gregoire to its Board of Directors
Business Wire - Mon Feb 09, 7:00AM CST
PerkinElmer, Inc. (NYSE
KI), a global leader focused on improving the health and safety of people and the environment, today announced that Sylvie Gregoire, Pharm. D., has been elected to its Board of Directors, effective February 6, 2015.
PKI: 46.30 (-0.10)
Analysts View on Health Care Sector Equities -- GlaxoSmithKline, Novartis, Illumina, PerkinElmer, and Albany Molecular Research
PR Newswire - Thu Feb 05, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: GlaxoSmithKline PLC (NYSE: GSK), Novartis AG (NYSE: NVS), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), and Albany Molecular Research Inc. (NASDAQ: AMRI). Free research report on GlaxoSmithKline can be accessed at http://get.Investor-Edge.com/pdf/?c=GlaxoSmit...&s=GSK. On Wednesday, February 04, 2015, the NASDAQ Composite ended at 4,716.70, down 0.23%, the Dow Jones Industrial Average advanced 0.04%, to finish the day at 17,673.02, and the S&P 500 closed at 2,041.51, down 0.42%. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 800.54, down 1.35%, while the index has advanced 2.67% in the previous three months. Register for your complimentary reports at the links given below.
ILMN: 198.54 (+1.81), GSK: 47.94 (+1.99), AMRI: 16.94 (-0.28), PKI: 46.30 (-0.10), NVS: 102.20 (-0.17)
PerkinElmer Elects Sylvie Gregoire to its Board of Directors
Business Wire - Mon Feb 09, 7:00AM CST
PerkinElmer, Inc. (NYSE
KI), a global leader focused on improving the health and safety of people and the environment, today announced that Sylvie Gregoire, Pharm. D., has been elected to its Board of Directors, effective February 6, 2015. PKI: 46.30 (-0.10)
Analysts View on Health Care Sector Equities -- GlaxoSmithKline, Novartis, Illumina, PerkinElmer, and Albany Molecular Research
PR Newswire - Thu Feb 05, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: GlaxoSmithKline PLC (NYSE: GSK), Novartis AG (NYSE: NVS), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), and Albany Molecular Research Inc. (NASDAQ: AMRI). Free research report on GlaxoSmithKline can be accessed at http://get.Investor-Edge.com/pdf/?c=GlaxoSmit...&s=GSK. On Wednesday, February 04, 2015, the NASDAQ Composite ended at 4,716.70, down 0.23%, the Dow Jones Industrial Average advanced 0.04%, to finish the day at 17,673.02, and the S&P 500 closed at 2,041.51, down 0.42%. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 800.54, down 1.35%, while the index has advanced 2.67% in the previous three months. Register for your complimentary reports at the links given below.
ILMN: 198.54 (+1.81), GSK: 47.94 (+1.99), AMRI: 16.94 (-0.28), PKI: 46.30 (-0.10), NVS: 102.20 (-0.17)
